Solriamfetol is a dopamine and norepinephrine reuptake inhibitor, trace amine-associated receptor 1 agonist, and 5-HT 1A agonist. It is currently approved under the brand name Sunosi ® to improve ...
Iovance stock drops 90% despite historic approval for Amtagvi. Click here for a full investment analysis of IOVA stock.
Two phase 2 trials with different selective TYK2 inhibitors produce high rates of efficacy in moderate to severe plaque ...
SHANGHAI, China I April 2, 2025 I Mabwell (688062.SH), an innovative biopharmaceutical company with entire industry chain, announced its novel B7-H3-targeting ...
Patient-reported outcomes measures in generalized myasthenia gravis (gMG) are more important than ever, for both those ...
Janus kinase (JAK) inhibitors, including ruxolitinib cream and abrocitinib, demonstrate strong efficacy in atopic dermatitis ...
A new study that looked at how liberal vs. restrictive fluid restriction impacts health status for patients with chronic ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback